MEGGLE (Business Unit Excipients)
Premium PartnerIs this your company? Claim this profile
Excipients & Specialty Ingredients
Regulatory, Tech Transfer & Support Services
Company Overview
About
MEGGLE (Business Unit Excipients) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Germany
Founded:2001
Employees:378
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval 2ZNP88
Health Canada · #APR-S90JLV9J · 2021-08-01
Drug Approval 7RFVO2
Health Canada · #APR-B5ZNWGM8 · 2018-05-01
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-USM09EJS
Issued: 2020-05-17
Expires: 2025-03-16
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-80NX3HYS
Issued: 2020-12-28
Expires: 2025-04-14
WHO GMP
World Health Organization
Cert #: CERT-SCBFYY2P
Issued: 2020-03-15
Expires: 2025-12-25
Health Canada GMP
Health Canada
Cert #: CERT-36D9OI50
Issued: 2020-06-20
Expires: 2025-03-20
Loading CDMO intelligence...
Key facts about MEGGLE (Business Unit Excipients)
- MEGGLE (Business Unit Excipients) is headquartered in Germany.
- MEGGLE (Business Unit Excipients) was founded in 2001.
- MEGGLE (Business Unit Excipients) has 378 employees.
- MEGGLE (Business Unit Excipients)'s capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like MEGGLE (Business Unit Excipients)
Directory pages this company appears in, each with the full list of matching manufacturers.